GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nymox Pharmaceutical Corp (OTCPK:NYMXF) » Definitions » Dividend Yield %

NYMXF (Nymox Pharmaceutical) Dividend Yield % : 0.00% (As of Mar. 17, 2025)


View and export this data going back to 1997. Start your Free Trial

What is Nymox Pharmaceutical Dividend Yield %?

As of today (2025-03-17), the Trailing Annual Dividend Yield of Nymox Pharmaceutical is 0.00%.

The historical rank and industry rank for Nymox Pharmaceutical's Dividend Yield % or its related term are showing as below:

NYMXF's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.42
* Ranked among companies with meaningful Dividend Yield % only.

Nymox Pharmaceutical's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00.

As of today (2025-03-17), the Forward Dividend Yield % of Nymox Pharmaceutical is 0.00%.

Nymox Pharmaceutical's Dividends per Share for the three months ended in Sep. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Nymox Pharmaceutical Dividend Yield % Historical Data

The historical data trend for Nymox Pharmaceutical's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nymox Pharmaceutical Dividend Yield % Chart

Nymox Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nymox Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Sep24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nymox Pharmaceutical's Dividend Yield %

For the Biotechnology subindustry, Nymox Pharmaceutical's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nymox Pharmaceutical's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nymox Pharmaceutical's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Nymox Pharmaceutical's Dividend Yield % falls into.



Nymox Pharmaceutical Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Nymox Pharmaceutical  (OTCPK:NYMXF) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Nymox Pharmaceutical Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Nymox Pharmaceutical's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nymox Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
Bay & Deveaux Streets, Nassau, BHS
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. It markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. It operates in a single segment, which is research and development of products for the aging population. The company's geographical segments include Canada, United States, and Europe.
Executives
James George Robinson director 10 EAST LEE STREET, SUITE 2705, BALTIMORE MD 21202
Erik Danielsen officer: Chief Financial Officer 9900 CAVENDISH BLVD, ST LAURENT A8 H4M 2V2
Paul Averback director, 10 percent owner, officer: CEO C/O NYMOX PHARMACEUTICAL CORPORATION, 9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT A8 H4M 2V2
Randall J Lanham director, officer: General Counsel

Nymox Pharmaceutical Headlines

From GuruFocus

NYMOX Appeals Deficiency Letter

By Stock market mentor Stock market mentor 01-06-2023

NYMOX Receives RTF letter from FDA

By GuruFocusNews GuruFocusNews 05-23-2022

Nymox Shareholder Update

By GuruFocusNews GuruFocusNews 12-13-2021

May 2023 Market Cap Requirement Update

By GlobeNewswire GlobeNewswire 11-25-2022

Nymox Provides Current Update

By sperokesalga sperokesalga 05-10-2023

NYMOX Receives RTF letter from FDA

By GuruFocusNews GuruFocusNews 06-02-2022

Nymox Delisting from NASDAQ

By Marketwired 07-05-2023

NYMOX Update

By Marketwired 07-07-2023